Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (50)
Tomohiko Kimura, Yukino Katakura, Masashi Shimoda, Fumiko Kawasaki, Mizuho Yamabe, Fuminori Tatsumi, Michihiro Matsuki, Yuichiro Iwamoto, Takatoshi Anno, Yoshiro Fushimi, Shinji Kamei, Yukiko Kimura, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku & Hideaki Kaneto. (2023)
Comparison of clinical efficacy and safety of weekly glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel‐group, multicentre, open‐label trial (
COMING
study)
. Diabetes, Obesity and Metabolism 25:12, pages 3632-3647.
Crossref
Crossref
Tomoaki Akiyama, Tadashi Yamakawa, Kazuki Orime, Masahiro Ichikawa, Marina Harada, Takumi Netsu, Ryoichi Akamatsu, Keita Nakamura, Satoru Shinoda & Yasuo Terauchi. (2023) Effects of hybrid closed‐loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor‐augmented pump: A prospective single‐center observational study. Journal of Diabetes Investigation.
Crossref
Crossref
Kazuki Aoyama, Yuya Nakajima, Shu Meguro, Yasunori Sato, Rei Goto, Mariko Hida, Takeshi Arimitsu, Yoshifumi Kasuga, Mamoru Tanaka & Hiroshi Itoh. (2023) Efficacy and safety of a telemedicine system in subjects with gestational diabetes mellitus (TELEGLAM): Study protocol for a randomized controlled trial. Heliyon 9:11, pages e22504.
Crossref
Crossref
Špela Volčanšek, Mojca Lunder & Andrej Janež. (2023) Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 Diabetes. Healthcare 11:15, pages 2154.
Crossref
Crossref
Mika Kurita, Hiroaki Satoh, Hideyoshi Kaga, Satoshi Kadowaki, Yuki Someya, Yuka Tosaka, Yuya Nishida, Fuki Ikeda, Yoshifumi Tamura & Hirotaka Watada. (2023)
A
7 day
inpatient diabetes education program improves quality of life and glycemic control 12 months after discharge
. Journal of Diabetes Investigation 14:6, pages 811-820.
Crossref
Crossref
Yuki Oe, Hiroshi Nomoto, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Akinobu Nakamura, Hideaki Miyoshi & Tatsuya Atsumi. (2022) Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM. Advances in Therapy 40:1, pages 383-386.
Crossref
Crossref
Masahiro Ichikawa, Tadashi Yamakawa, Rika Sakamoto, Kenichiro Takahashi, Jun Suzuki, Minori Matsuura-Shinoda, Erina Shigematsu, Shunichi Tanaka, Mizuki Kaneshiro, Taro Asakura, Takehiro Kawata, Yoshihiko Yamada, Uru Nezu Osada, Tetsuo Isozaki, Atsushi Takahashi, Kazuaki Kadonosono & Yasuo Terauchi. (2022) A cross-sectional study of the relationship between quality of life and sleep quality in Japanese patients with type 1 diabetes mellitus. Endocrine Journal 69:4, pages 399-406.
Crossref
Crossref
Nagaaki Tanaka, Daisuke Yabe, Kenta Murotani, Yuko Yamaguchi, Yuki Fujita, Sodai Kubota, Rena Nakashima‐Yasuda, Saki Kubota‐Okamoto, Shinji Ueno, Yuji Yamazaki, Hitoshi Kuwata, Koin Watanabe, Takanori Hyo, Yoshiyuki Hamamoto, Takeshi Kurose, Hiroko Higashiyama, Yusuke Seino, Yuichiro Yamada & Yutaka Seino. (2021) Effects of physician’s diabetes self‐management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self‐monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open‐labeled, prospective randomized clinical trial. Journal of Diabetes Investigation 12:12, pages 2221-2231.
Crossref
Crossref
Yasuyo Ando, Fumika Shigiyama, Takahisa Hirose & Naoki Kumashiro. (2021) Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well‐controlled type 2 diabetes: A 24‐week randomized controlled trial. Journal of Diabetes Investigation 12:10, pages 1816-1826.
Crossref
Crossref
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, Toshihiko Shiraiwa, Tetsuyuki Yasuda, Yosuke Okada, Keiichi Torimoto, Yutaka Umayahara, Hideaki Kaneto, Takeshi Osonoi, Tsunehiko Yamamoto, Nobuichi Kuribayashi, Kazuhisa Maeda, Hiroki Yokoyama, Keisuke Kosugi, Kentaro Ohtoshi, Isao Hayashi, Satoru Sumitani, Mamiko Tsugawa, Kayoko Ryomoto, Hideki Taki, Tadashi Nakamura, Satoshi Kawashima, Yasunori Sato, Hirotaka Watada, Iichiro Shimomura, I. Hayashi, M. Tsugawa, H. Yokoyama, H. Yoshii, K. Komiyama, T. Mita, T. Shimizu, T. Yamamoto, S. Kawashima, T. Nakamura, S. Kamei, T. Kinoshita, M. Shimoda, K. Maeda, K. Kosugi, H. Yoshii, H. Ishida, T. Osonoi, M. Saito, A. Tamazawa, S. Sumitani, N. Fujiki, Y. Fujita, S. Shimizu, Y. Umayahara, K. Kato, Y. Irie, R. Kataoka, T. Yasuda, Y. Kiyohara, M. Ohashi, K. Ryomoto, Y. Takahi, Y. Fujishima, Y. Fujita, A. Fukuhara, K. Fukui, Y. Hosokawa, A. Imagawa, H. Iwahashi, K. Mukai, N. Katakami, T. Katsura, D. Kawamori, T. Kimura, S. Kobayashi, J. Kozawa, F. Kubo, N. Maeda, T. Matsuoka, K. Miyashita, S. Nakata, H. Ninomiya, H. Nishizawa, Y. Okuno, M. Otsuki, F. Sakamoto, S. Sasaki, I. Sato, N. Shimo, I. Shimomura, M. Takahara, T. Takano, A. Tokunaga, S. Uno, M. Yamaoka, S. Yoneda, K. Ohtoshi, T. Shiraiwa, M. Hajime, K. Koikawa, F. Kuno, A. Kurozumi, K. Matsushita, M. Narisawa, K. Tanaka, K. Sugai, Y. Okada & K. Torimoto. (2021) The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus. Diabetes Therapy 12:9, pages 2499-2515.
Crossref
Crossref
Ryotaro BouchiKazuo IzumiHiroshi OhtsuKengo MiyoShigeho TanakaNoriko Satoh-AsaharaKazuo HaraMasato OdawaraYoshiki KusunokiHidenori KoyamaTakeshi OnoueHiroshi ArimaKazuyo TsushitaHirotaka WatadaTakashi KadowakiKohjiro Ueki. (2021) Prevention of Worsening Diabetes through Behavioral Changes by an IoT-based Self-Monitoring System in Japan (PRISM-J): Study design and rationale for a multicenter, open-label, randomized parallel-group trial. GHM Open 1:1, pages 3-11.
Crossref
Crossref
Yuta Yoshizawa, Michihiro Hosojima, Hideyuki Kabasawa, Naohito Tanabe, Daisuke Ugamura, Yutaka Koda, Hisaki Shimada, Tetsuya Takasawa, Takahito Ito, Tadahiro Kitamura, Masaki Kobayashi, Yoshiki Suzuki, Ichiei Narita & Akihiko Saito. (2021) Effects of the Once-Weekly DPP4 Inhibitor Omarigliptin on Glycemic Control in Patients with Type 2 Diabetes Mellitus on Maintenance Hemodialysis: A 24-Week Open-Label, Multicenter Randomized Controlled Study. Diabetes Therapy 12:3, pages 655-667.
Crossref
Crossref
Tomoyuki Katsuno, Toshihiko Shiraiwa, Shingo Iwasaki, Hyohun Park, Nobuaki Watanabe, Shizuka Kaneko, Jungo Terasaki, Toshiaki Hanafusa, Akihisa Imagawa, Iichiro Shimomura, Hiroshi Ikegami, Hidenori Koyama, Mitsuyoshi Namba & Jun-ichiro Miyagawa. (2021) Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2). Advances in Therapy 38:3, pages 1514-1535.
Crossref
Crossref
Hitoshi Ishii, Brian B. Hansen, Jakob Langer & Hiroshi Horio. (2021) Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial. Diabetes Therapy 12:2, pages 613-623.
Crossref
Crossref
Hitoshi Ishii, Hiroki Nakajima, Nozomu Kamei, Tetsuji Niiya, Toru Hiyoshi, Yuko Hiramori, Shigeyuki Ohtsu, Takashi Noto & Dai Shimono. (2020) Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (J-BOND Study). Diabetes Therapy 11:12, pages 2959-2977.
Crossref
Crossref
Hitoshi Ishii, Hiroshi Takamura, Yuichi Nishioka, Jakob Langer, Michihisa Watanabe, Hyunchung Ray Kim & Bruce Crawford. (2020) Quality of Life and Utility Values for Cost-Effectiveness Modeling in Japanese Patients with Type 2 Diabetes. Diabetes Therapy 11:12, pages 2931-2943.
Crossref
Crossref
Keisuke Ueno, Daisuke Chujo, Nobuyuki Takahashi, Mitsuru Ohsugi, Kohjiro Ueki & Hiroshi Kajio. (2020) Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study. Diabetes Therapy 11:8, pages 1883-1890.
Crossref
Crossref
Lorenzo Palamenghi, Milvia Marta Carlucci & Guendalina Graffigna. (2020) Measuring the Quality of Life in Diabetic Patients: A Scoping Review. Journal of Diabetes Research 2020, pages 1-19.
Crossref
Crossref
Hitoshi Ishii, Suzuki Shuichi, Paul Williams, Sven Demiya, Toshihiko Aranishi & Tamas Treuer. (2020) Cross-sectional survey in patients with type 1 and type 2 diabetes to understand mealtime insulin unmet needs in Japan: The MINUTES-J study. Diabetes Research and Clinical Practice 162, pages 108076.
Crossref
Crossref
Hitoshi Ishii, Yukiko Onishi, Tomonori Oura & Masakazu Takeuchi. (2019) Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study. Diabetes Therapy 11:1, pages 133-145.
Crossref
Crossref
Yu Ting Chen, Yan Zhi Tan, Mcvin Cheen & Hwee-Lin Wee. (2019) Patient-Reported Outcome Measures in Registry-Based Studies of Type 2 Diabetes Mellitus: a Systematic Review. Current Diabetes Reports 19:11.
Crossref
Crossref
Tomoya Mita, Naoto Katakami, Yosuke Okada, Hidenori Yoshii, Takeshi Osonoi, Keiko Nishida, Toshihiko Shiraiwa, Keiichi Torimoto, Akira Kurozumi, Satomi Wakasugi, Masahiko Gosho, Iichiro Shimomura & Hirotaka Watada. (2019) Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes. Diabetes Therapy 10:5, pages 1565-1575.
Crossref
Crossref
Hitoshi Ishii, Yuki Suzaki, Yuko Miyata & Shingo Matsui. (2019) Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor. Diabetes Therapy 10:4, pages 1369-1380.
Crossref
Crossref
Takahiro Takase, Akinobu Nakamura, Chiho Yamamoto, Hiroshi Nomoto, Aika Miya, Midori Dannoura, Kyu Yong Cho, Yoshio Kurihara, Naoki Manda, Shin Aoki, Tatsuya Atsumi & Hideaki Miyoshi. (2018) Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial. Journal of Diabetes Investigation 10:3, pages 699-705.
Crossref
Crossref
Hitoshi Ishii, Hyunchung Ray Kim & Bruce Crawford. (2018) The revalidation of the diabetes treatment-related quality-of-life (DTR-QOL) questionnaire in Japan. Diabetology International 10:2, pages 93-101.
Crossref
Crossref
Fukumi Yoshikawa, Naoki Kumashiro, Fumika Shigiyama, Hiroshi Uchino, Yasuyo Ando, Hiroshi Yoshino, Masahiko Miyagi, Kayoko Ikehara & Takahisa Hirose. (2018) Efficacy of intermittent empagliflozin supplementation on dietary self‐management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24‐week randomized controlled trial. Diabetes, Obesity and Metabolism 21:2, pages 303-311.
Crossref
Crossref
Tomoya Mita, Toru Hiyoshi, Hidenori Yoshii, Hiroko Chimori, Kazuo Ikeda, Miho Shimizu, Yuichi Kojima, Hareaki Yamamto, Daijiro Yasuda, Junko Sato & Hirotaka Watada. (2018) The Effect of Linagliptin versus Metformin Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus. Diabetes Therapy 10:1, pages 119-134.
Crossref
Crossref
Naoyuki Odaguchi, Tsuyako Shimajiri, Ayako Tamaki, Miki Inamine, Hiroko Noomo, Haruna Sunakawa, Reina Yonamine, Iori Yamada, Madoka Uezato, Mariko Kaneshiro & Kazushi Kinjo. (2019) Experience of the use of a flash glucose monitoring system by hemodialysis patients血液透析患者へのフラッシュグルコースモニタリングシステム (FGM) の使用経験. Nihon Toseki Igakkai Zasshi 52:5, pages 253-260.
Crossref
Crossref
Haruka Ueno, Hirono Ishikawa, Ryo Suzuki, Yoshihiko Izumida, Yumiko Ohashi, Toshimasa Yamauchi, Takashi Kadowaki & Takahiro Kiuchi. (2019) The association between health literacy levels and patient-reported outcomes in Japanese type 2 diabetic patients. SAGE Open Medicine 7, pages 205031211986564.
Crossref
Crossref
Jean-Noel Vergnes, Thibault Canceill, Alexia Vinel, Sara Laurencin-Dalicieux, Françoise Maupas-Schwalm, Vincent Blasco-Baqué, Hélène Hanaire, Elise Arrivé, Vincent Rigalleau, Cathy Nabet, Michel Sixou, Pierre Gourdy & Paul Monsarrat. (2018) The effects of periodontal treatment on diabetic patients: The DIAPERIO randomized controlled trial. Journal of Clinical Periodontology 45:10, pages 1150-1163.
Crossref
Crossref
Tomoya Mita, Toru Hiyoshi, Hidenori Yoshii, Hiroko Chimori, Kazuo Ikeda, Junko Sato & Hirotaka Watada. (2018) Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial. Diabetes Therapy 9:3, pages 1403-1412.
Crossref
Crossref
Susanna Dodd, Mike Clarke, Lorne Becker, Chris Mavergames, Rebecca Fish & Paula R. Williamson. (2018) A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery. Journal of Clinical Epidemiology 96, pages 84-92.
Crossref
Crossref
Naotaka Fujita, Yosuke Yamamoto, Yasuaki Hayashino, Hirohito Kuwata, Shintaro Okamura, Tadao Iburi, Miyuki Furuya, Masako Kitatani, Shin Yamazaki, Hitoshi Ishii, Satoru Tsujii, Nobuya Inagaki & Shunichi Fukuhara. (2017) Real‐life glycemic control in patients with type 2 diabetes treated with insulin therapy: A prospective, longitudinal cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 9]). Journal of Diabetes Investigation 9:2, pages 294-302.
Crossref
Crossref
Yasuaki Hayashino, Satoru Tsujii & Hitoshi Ishii. (2017) Association of diabetes therapy-related quality of life and physical activity levels in patients with type 2 diabetes receiving medication therapy: the Diabetes Distress and Care Registry at Tenri (DDCRT 17). Acta Diabetologica 55:2, pages 165-173.
Crossref
Crossref
Hiromasa Goto, Tomoya Mita, Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, Hiroaki Satoh, Takahisa Hirose, Toru Hiyoshi, Masumi Ai, Yosuke Okada, Hideki Nishimura, Hisamoto Kuroda, Toshiki Matsubara, Masahiko Gosho, Hitoshi Ishii & Hirotaka Watada. (2018) Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP study. Endocrine Journal 65:6, pages 657-668.
Crossref
Crossref
Mayuko Oita, Hideaki Miyoshi, Kota Ono, Akinobu Nakamura, Kyu Yong Cho, Hiroshi Nomoto, Kohei Yamamoto, Kazuno Omori, Naoki Manda, Yoshio Kurihara, Shin Aoki & Tatsuya Atsumi. (2018) Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes—Randomized controlled study—. Endocrine Journal 65:2, pages 141-150.
Crossref
Crossref
Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Kyu Yong Cho, So Nagai, Yoshio Kurihara, Shin Aoki, Masataka Taguri, Yasuo Terauchi & Tatsuya Atsumi. (2017) Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial. Journal of Diabetes Investigation 9:1, pages 119-126.
Crossref
Crossref
Sumie Mitsuishi, Rimei Nishimura, Shin-ichi Harashima, Tomoyuki Kawamura, Daisuke Tsujino, Keiko Koide, Akiko Nishimura, Kazunori Utsunomiya, Nobuya Inagaki & Yoshihito Atsumi. (2017) The Effect of Novel Glucose Monitoring System (Flash Glucose Monitoring) on Mental Well-being and Treatment Satisfaction in Japanese People with Diabetes. Advances in Therapy 35:1, pages 72-80.
Crossref
Crossref
Hitoshi Ishii, Tetsuji Niiya, Yasuhiro Ono, Naoyuki Inaba, Hideaki Jinnouchi & Hirotaka Watada. (2017) Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study. Diabetology & Metabolic Syndrome 9:1.
Crossref
Crossref
Hitoshi Ishii, Yuki Suzaki & Yuko Miyata. (2017) Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol. Diabetes Therapy 8:6, pages 1415-1425.
Crossref
Crossref
Hirofumi Mizuno, Daisuke Ekuni, Takayuki Maruyama, Kota Kataoka, Toshiki Yoneda, Daiki Fukuhara, Yoshio Sugiura, Takaaki Tomofuji, Jun Wada & Manabu Morita. (2017) The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: A randomized clinical trial. PLOS ONE 12:11, pages e0188171.
Crossref
Crossref
Yoshimasa Aso, Kunihiro Suzuki, Yasuko Chiba, Minoru Sato, Nobuya Fujita, Yoshihisa Takada, Shunichi Murano & Hisamoto Kuroda. (2017) Effect of insulin degludec versus insulin glargine on glycemic control and daily fasting blood glucose variability in insulin-naïve Japanese patients with type 2 diabetes: I’D GOT trial. Diabetes Research and Clinical Practice 130, pages 237-243.
Crossref
Crossref
Mitsutoshi Kato, Kumiko Sakai, Kyoko Saito, Kensuke Tsutsui, Shigeo Yamashita & Noriko Kato. (2017) Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin. Diabetology International 8:3, pages 275-285.
Crossref
Crossref
Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, Hidenori Yoshii, Masahiko Gosho, Hitoshi Ishii, Iichiro Shimomura & Hirotaka Watada. (2017) The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis. Diabetes Therapy 8:3, pages 693-704.
Crossref
Crossref
Ryotaro Bouchi, Yujiro Nakano, Tatsuya Fukuda, Takato Takeuchi, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto & Yoshihiro Ogawa. (2017) Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial. Endocrine Journal 64:3, pages 269-281.
Crossref
Crossref
Ayumi Sugawara Hirose, Kazuya Fujihara, Flaminia Miyamasu, Shigeru Iwakabe, Misa Shimpo, Yoriko Heianza, Chika Horikawa, Yoko Yachi & Hirohito Sone. (2016) Development and evaluation of the Japanese version of the Audit of Diabetes-Dependent Quality of Life for patients with diabetes. Diabetology International 7:4, pages 384-390.
Crossref
Crossref
Kazuhiro Kobuke, Masayasu Yoneda, Shuhei Nakanishi, Haruya Ohno, Shusaku Maeda & Genshi Egusa. (2015) Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice. Journal of Diabetes Investigation 7:1, pages 94-99.
Crossref
Crossref
Morihiro Okada, Masae Okada, Jun Nishigami, Naoto Yamaaki, Kenji Furukawa, Kiminori Ohyama, Tsutomu Shimada & Yoshimichi Sai. (2015) Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus. Journal of Pharmaceutical Health Care and Sciences 1:1.
Crossref
Crossref
Tsuyoshi Mashitani, Yasuaki Hayashino, Shintaro Okamura, Masako Kitatani, Miyuki Furuya, Tadao Iburi, Hirohito Kuwata, Satoru Tsujii & Hitoshi Ishii. (2015) Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8). Acta Diabetologica 52:4, pages 639-647.
Crossref
Crossref
Hirohito Kuwata, Satoru Tsujii, Naotaka Fujita, Shintaro Okamura, Tadao Iburi, Tsuyoshi Mashitani, Masako Kitatani, Miyuki Furuya, Yasuaki Hayashino & Hitoshi Ishii. (2014) Switching from Insulin to Liraglutide Improved Glycemic Control and the Quality of Life Scores in a Case of Type 2 Diabetes and Active Crohn's Disease. Internal Medicine 53:15, pages 1637-1640.
Crossref
Crossref